Cytocell Ltd. recalled the CytoCell BCL11B Proximal in FITC Spectrum-LDT for investigation of T-cell related malignancy due to a mislabeled package insert, according to the FDA. The Food and Drug Administration announced the Class II recall on Oct. 27, 2022.
How to tell if you have it
- Brand: Cytocell
- Product: CytoCell BCL11B Proximal in FITC Spectrum-LDT for investigation T-cell related malignancy
- Ref: MPD39781
- Lot: RD22/230/10
- Distribution: TX
The hazard
The package insert for this analyte specific reagent probe contains an incorrect chromomap that does not match the probe design or specification. The image showing the position the FISH probe maps to on the specific chromosome is erroneous in version 1 of the insert.
Context
GovInfoNow's records show Cytocell Ltd. has 12 other recalls on record since March 15, 2019. Other recent recalls of similar products include HydroMARK Breast Biopsy Marker Recall (April 24, 2026) and Hologic ThinPrep CytoLyt Solution Recall (Dec. 12, 2025).